Advancement through adversity: how Covid-driven innovations are becoming best practices for pharmacovigilance
Pharmaceutical Technology
SEPTEMBER 7, 2022
Before drugs are authorised, evidence of their safety and efficacy is limited to results from clinical trials, so it is essential that pharmacovigilance continues after a therapy has been approved. After AEs are recorded, they must be translated and put back out to doctors and scientists for processing.
Let's personalize your content